The independent source for health policy research, polling, and news.
81 - 100 of 223 Results
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?
Creole-speaking public health workers teach women how to test themselves for HPV, the virus that causes some cervical cancers.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results.
As abortion restrictions take effect across the South in the wake of the Supreme Court’s decision to overturn Roe v. Wade, cancer doctors are trying to decipher the laws. They’re grappling with how to discuss options with pregnant patients, who may be forced to choose whether to proceed or forgo lifesaving cancer treatments that can prove toxic for the fetus.
A federal judge in Texas issued a decision this week that affects the Affordable Care Act. It says one way that preventive services are selected for no-cost coverage is unconstitutional.
Chimeric antigen receptor T-cell therapy has eliminated tumors in some late-stage cancer patients, but the cost and complexity of care mean rural Americans have trouble accessing the treatment.
An online calculator told a young woman that a procedure to rule out cancer would cost an uninsured person about $1,400. Instead, the hospital initially charged almost $18,000 and, with her high-deductible health insurance, she owed more than $5,000.
Inflation hasn’t hit Americans like this in decades. And families living with chronic diseases have little choice but to pay more for the medicine, supplies, and food they need to stay healthy.
Le Roy and Rosie Torres founded the Burn Pits 360 group that advocated for years for Congress to help veterans suffering from injuries caused by the massive disposal sites on overseas bases. Le Roy came home from Iraq suffering from breathing problems.
Private equity firms are seeing opportunities for profit in hospice care, once the domain of nonprofit organizations. The investment companies are transforming the industry — and might be jeopardizing patient care — in the process.
Medical breakthroughs mean cancer is less likely to kill, but survival can come at an extraordinary cost as patients drain savings, declare bankruptcy, or lose their homes, a KHN-NPR investigation finds.
Joe Pitzo was diagnosed with brain cancer in 2018. After surgery, the bills topped $350,000. “This just took a major toll on my credit,” Joe said. “It went down to next to nothing.”
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
Katie Coleman’s friends warned her not to tell prospective employers about her cancer diagnosis, fearing it would jeopardize her chances of being hired — even though it’s illegal for employers to discriminate because of a medical condition.
More than 20 years after the terrorist attacks, the World Trade Center Health Program is considering covering the most common form of uterine cancer, in what patient advocates say is a key acknowledgment of the women affected by the 9/11 fallout.
After the National Cancer Act became law 50 years ago, cancer went from shameful taboo to one of the best-funded areas of medicine. Much of the credit for this transformation goes to one woman, Mary Lasker.
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
Dr. Susan Massad created a “health team” after learning she had metastatic breast cancer. These friends and family members help her make difficult decisions and lead the most fulfilling life possible.
© 2026 KFF